Delayed data delivery is a growing problem
It’s 2021, and the digital revolution is well on its way. Yet, for clinical trials worldwide, real-time access to data is not the norm — and that lack can create a cascading set of issues affecting every aspect of a study. With critical decisions too often being made in a digital data vacuum, at best, processes are not as efficient as they could be, at worst, serious problems may go undetected for weeks or even months.
As the amount and types of data expand exponentially, this problem only intensifies. Yet, ironically, that very growth in data sources may be one reason solutions have been slow to take hold. In a recent analysis, the Tufts Center for the Study for Drug Development reported that more than two-thirds of all sponsors are using at least four different data sources.
In this white paper you’ll learn:
- How a lack of timely data can create catastrophic setbacks
- New technology solutions that can speed insights, enhance safety and produce cost-savings
- How real-time data synthesis and analysis can revolutionize your clinical trials